Home page > Health, wealth and equity | Health promoting socio-economic framework

Health Inequalities


Please find all related articles below.



[Updated briefing notes] The impact of the economic crisis on public health


October 2014 - In 2012, EPHA published its first ‘facts and figures’ briefing on the impacts of the economic crisis on health. Two years later, the revised and updates briefing finds that the impacts of austerity politics and economic recession continue to threaten the health and wellbeing of Europeans. Trends in increased suicide rates, unemployment, social exclusion and unmet health needs prevail, most acutely in the newer member states and in those receiving financial (...)
21/11/2014

Health groups express dismay at potential withdrawal of EU Clean Air Policy Package


Brussels, 18 November 2014 - Today, public health, patients’, and medical organisations sent a letter to EU Commission President Juncker expressing their dismay at any consideration to withdraw the EU Clean Air Policy Package, as presented by EU Environment and Health Commissioners Potocnik and Borg in December 2013. The letter calls on President Juncker to keep the proposal and work with the European Parliament and Council to ensure a swift and ambitious adoption. You can download (...)
18/11/2014

[Report] Patients suffering from medicines shortages in all European countries


A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines with 66% reporting this as a daily or weekly problem. The top affected areas are medicines to fight infection, cancer drugs and anesthetics. Brussels, 17 November 2014 - The report by the European Association of Hospital Pharmacists (EAHP), surveyed the experiences of over 600 hospital pharmacists in 36 European (...)
17/11/2014

[Letter: EPHA President] Upcoming meeting of the EPSCO Council – Europe 2020 and the AGS


Early next year the European Commission will issue its report on the mid-term review of the Europe 2020 Strategy. The EPSCO Council has been a major contributor to the review and has a vital role to play in adapting the Europe 2020 Strategy in light of pressing employment, social exclusion and poverty issues. 14 November 2014, Brussels To the attention of Ministers of Health RE: Upcoming meeting of the EPSCO Council – Europe 2020 and the AGS Dear Minister, In October, the Council (...)
14/11/2014

Carlos Moedas » European Commissioner for Research, Science and Innovation


Carlos Moedas (age 44) studied engineering at Lisbon University, Portugal and an MBA at Harvard University, USA. He worked for Goldman Sachs and EuroHypo investment bank before returning to Portugal in 2004 to join a property consulting company, and established his own property investment company in 2008. He led negotiations for the Social Democratic Party (PSD) for Portugal’s 2011 State Budget. He was elected as an MP in the same year, and leading implementation of the (...)
05/11/2014

[TTIP & Transparency Consultation] EPHA answers to the European Ombudsman Mrs Emily O’Reilly


Brussels, 30 October 2014 - On 29 July 2014, the European Ombudsman opened an own-initiative inquiry towards the European Commission concerning transparency and public participation in relation to the TTIP negotiations (OI/10/2014/RA). The present public consultation concerns that inquiry. The outcome of the TTIP negotiations could have a significant impact on the lives of citizens. The aim of the Ombudsman’s inquiry is to help ensure that the public can follow the progress of these (...)
30/10/2014

[Press release] The European Parliament will not gain people’s trust by continuing to contribute to the burden of chronic disease in the form of tobacco subsidies


Brussels, 23 October 2014 – Among all the furore yesterday of the new Commission, the European Parliament also quietly voted against ending EU subsidies to tobacco crops (1). While on the one hand many MEPs so supportive of legislating in favour of health with regards to pharmaceutical products, it seems that over half of the EP is happy to continue pumping taxpayer’s money to a harmful industry (2) instead of supporting farmers to make the shift to a more health and sustainable (...)
23/10/2014

New European Parliament and Gender Equality post-2015: taking stock of progress made, where’s health?


The European Parliament Committee on Gender Equality (FEMM Committee) has started making post-2015 plans for a new gender equality strategy. Debating a report written by MEP Maria Noichl, S&D, DE on how to improve equality after 2015, the new strategy comes in light of an upcoming report on progress made since 2013 being compiled by MEP Marc Tarabella (S&D, BE). On 13 October 2014, EP FEMM Committee discussed the progress made in 2013 with experts, which will be fed into an (...)
23/10/2014

New study calls upon EU to address link between mental and physical health in its Health Programme


A new study commissioned by Mental Health Europe assesses whether the EU’s second Health Programme (2008-2013) addresses the interrelation of mental and physical health. The conclusion is that the programme does not make a sufficient connection between the two. This is unfortunate as a more thorough consideration of this link could contribute to the prevention of comorbidity. Earlier studies have shown that physical and mental health related problems are closely linked. People with (...)
23/10/2014

[Joint press release] The European Health Community welcomes President-elect Juncker’s decision to ensure the security of all Europeans by regulating health for the public good


October 22th 2014, Brussels – The NGO signatories of this statement wholeheartedly welcome the announcement of the reversal of the decision by President-elect Jean-Claude Juncker to move the competence for pharmaceutical and medical devices to the enterprise directorate (1). Following negotiations within the European Parliament and concerns expressed by a number of member states, President-elect Juncker stated today that the "responsibility for medicines and pharmaceutical products (...)
22/10/2014